Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pulmonx (LUNG) Return on Sales (2019 - 2025)

Historic Return on Sales for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to 0.65%.

  • Pulmonx's Return on Sales rose 500.0% to 0.65% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.62%, marking a year-over-year increase of 1000.0%. This contributed to the annual value of 0.67% for FY2024, which is 2100.0% up from last year.
  • Per Pulmonx's latest filing, its Return on Sales stood at 0.65% for Q3 2025, which was up 500.0% from 0.64% recorded in Q2 2025.
  • In the past 5 years, Pulmonx's Return on Sales registered a high of 0.55% during Q4 2024, and its lowest value of 1.47% during Q1 2022.
  • Moreover, its 5-year median value for Return on Sales was 0.85% (2023), whereas its average is 0.89%.
  • Examining YoY changes over the last 5 years, Pulmonx's Return on Sales showed a top increase of 21900bps in 2021 and a maximum decrease of -5300bps in 2021.
  • Pulmonx's Return on Sales (Quarter) stood at 0.95% in 2021, then grew by 2bps to 0.93% in 2022, then increased by 22bps to 0.72% in 2023, then grew by 23bps to 0.55% in 2024, then dropped by -17bps to 0.65% in 2025.
  • Its Return on Sales was 0.65% in Q3 2025, compared to 0.64% in Q2 2025 and 0.64% in Q1 2025.